首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
【24h】

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

机译:缺乏KIT和PDGFRA突变的胃肠道间质瘤中琥珀酸脱氢酶的缺陷

获取原文
获取原文并翻译 | 示例
       

摘要

Carney-Stratakis syndrome, an inherited condition predisposing affected individuals to gastrointestinal stromal tumor (GIST) and paraganglioma, is caused by germline mutations in succinate dehydrogenase (SDH) subunits B, C, or D, leading to dysfunction of complex II of the electron transport chain. We evaluated the role of defective cellular respiration in sporadic GIST lacking mutations in KIT or PDGFRA (WT). Thirty-four patients with WT GIST without a personal or family history of paraganglioma were tested for SDH germline mutations. WT GISTs lacking demonstrable SDH genetic inactivation were evaluated for SDHB expression by immuno-histochemistry and Western blotting and for complex II activity. For comparison, SDHB expression was also determined in KIT mutant and neurofibromatosis-1-associated GIST, and complex II activity was also measured in SDH-deficient paraganglioma and KIT mutant GIST; 4 of 34 patients (12%) with WT GIST without a personal or family history of paraganglioma had germline mutations in SDHB or SDHC. WT GISTs lacking somatic mutations or deletions in SDH sub-units had either complete loss of or substantial reduction in SDHB protein expression, whereas most KIT mutant GISTs had strong SDHB expression. Complex II activity was substantially decreased in WT GISTs. WT GISTs, particularly those in younger patients, have defects in SDH mitochondrial complex II, and in a subset of these patients, GIST seems to arise from germline-inactivating SDH mutations. Testing for germline mutations in SDH is recommended in patients with WT GIST. These findings highlight a potential central role of SDH dysregulation in WT GIST oncogenesis.
机译:Carney-Stratakis综合征是一种遗传病,易使受影响的人患上胃肠道间质瘤(GIST)和副神经节瘤,是由琥珀酸脱氢酶(SDH)B,C或D亚基的种系突变引起的,导致电子转运复合体II功能异常链。我们评估了细胞呼吸不良在散发性GIST缺乏KIT或PDGFRA(WT)突变中的作用。没有个人或家族性副神经节瘤病史的WT GIST的34例患者接受了SDH种系突变的检测。缺乏可证明的SDH遗传失活的WT GIST通过免疫组织化学和Western印迹评估了SDHB的表达以及复合体II的活性。为了进行比较,还测定了KIT突变体和与神经纤维瘤病1相关的GIST中的SDHB表达,还测定了SDH缺乏的副神经节瘤和KIT突变体GIST中的复合物II活性。没有个人或家族性副神经节瘤病史的WT GIST患者中,有34例中有4例(12%)的SDHB或SDHC有种系突变。 SDH亚基中缺乏体细胞突变或缺失的WT GISTs,SDHB蛋白表达完全丧失或显着降低,而大多数KIT突变体GISTs具有很强的SDHB表达。在WT GISTs中,复合物II活性显着降低。 WT GIST,特别是年轻患者的GIST,在SDH线粒体复合体II中存在缺陷,在这些患者的一部分中,GIST似乎是由种系失活的SDH突变引起的。 WT GIST患者建议测试SDH中的种系突变。这些发现突显了SDH失调在WT GIST肿瘤发生中的潜在中心作用。

著录项

  • 来源
  • 作者单位

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Pediatric Oncology Branch,National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;

    Section on Endocrinology and Genetics, Program on Developmental Endocrinology Genetics, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;

    Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136;

    Inserm U676 and Universite Paris 7, Faculte de Medecine Denis Diderot, IFR02 Paris, France;

    Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, 3000 CA, Rotterdam, The Netherlands;

    Departments of Medicine and Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, TX 78229;

    Institute of Pathology, Medical University, 8036 Graz, Austria;

    Section on Endocrinology and Genetics, Program on Developmental Endocrinology Genetics, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;

    Program on Developmental Endocrinology Genetics, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115,;

    Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, 3000 CA, Rotterdam, The Netherlands;

    Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, 3000 CA, Rotterdam, The Netherlands;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA 02115;

    Pediatric Oncology Branch,National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;

    Section on Endocrinology and Genetics, Program on Developmental Endocrinology Genetics, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    genetic predisposition; sarcoma; pediatric;

    机译:遗传易感性;肉瘤;儿科;
  • 入库时间 2022-08-18 00:40:40

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号